Explore pivotal recommendations from the latest evidence-based clinical practice guidance with ASCO Guidelines. Join us to discover essential insights and navigate the ever-evolving landscape of cancer research and treatment.
Publishes | Weekly | Episodes | 186 | Founded | 8 years ago |
---|---|---|---|---|---|
Number of Listeners | Categories | Health & FitnessMedicine |
Dr. Tanya Thomas and Dr. Aparna Jotwani join the podcast to discuss the new Oncology Nursing Society and American Society of Clinical Oncology evidence-based guideline on the management of antineoplastic extravasation. They discuss recommendations fr... more
Dr. Kathleen Horst, Dr. Rachel Jimenez, and Dr. Yara Abdou discuss the updated guideline from ASTRO, ASCO, and SSO on postmastectomy radiation therapy. They share new and updated recommendations on topics including PMRT after upfront surgery, PMRT af... more
Dr. Cris Bergerot and Dr. Enrique Soto join the podcast to discuss the new global guideline on geriatric assessment. This guideline provides evidence-based, resource-stratified recommendations across the basic, limited, and enhanced settings. Dr. Ber... more
Ms. Kim Woofter and Dr. John Cox discuss the latest updates to the evidence-based standards on oncology medical homes developed by ASCO and COA. These standards serve as the basis for the ASCO Certified program. They share the new and revised standar... more
People also subscribe to these shows.
Excellent podcasts
Excellent summary!
Great way to keep tabs on the latest innovations in oncology, all while raising up a range of voices in the practice. And an excellent host!
This podcast is always educational, organized, and succinct. An excellent program!
I think this podcast is great becuase it's usually very relevant to practicing oncologists but it's also quick. I can generally listen to it over my commute.
Key themes from listener reviews, highlighting what works and what could be improved about the show.
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #210 | |
Apple Podcasts | #186 | |
Apple Podcasts | #245 | |
Apple Podcasts | #29 | |
Apple Podcasts | #46 | |
Apple Podcasts | #101 |
Recent interactions between the hosts and their guests.
Listeners, social reach, demographics and more for this podcast.
Listeners per Episode | |
---|---|
Gender Skew | |
Location | |
Interests | |
Professions | |
Age Range | |
Household Income | |
Social Media Reach |
Focused on the evolving landscape of cancer research and treatment, this series highlights pivotal evidence-based clinical practice guidelines. Through engaging discussions with experts, listeners gain insights into the latest advancements and recommendations that directly impact patient care in oncology. Topics frequently addressed include symptom management, treatment strategies for various cancers, and the importance of multidisciplinary approaches to enhance patient outcomes. Unique to this series is its commitment to translating complex medical guidelines into accessible information for practitioners, making it a valuable resource for healthcare professionals and stakeholders involved in cancer treatment.
Rephonic provides a wide range of podcast stats for ASCO Guidelines. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to ASCO Guidelines and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for ASCO Guidelines, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for ASCO Guidelines, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers ASCO Guidelines has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with ASCO Guidelines:
1. Two Onc Docs
2. ASCO Daily News
3. Journal of Clinical Oncology (JCO) Podcast
4. ASCO Education
5. Oncology Brothers: Practice-Changing Cancer Discussions
ASCO Guidelines launched 8 years ago and published 186 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for ASCO Guidelines from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of ASCO Guidelines. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.
Recent guests on ASCO Guidelines include:
1. Dr. Joshua Reuss
2. Michael Reff
3. Dr. Luis Reyes
4. Dr. Kim Perez
5. Dr. Jaydira Del Rivero
6. Dr. Rohan Garje
7. Jaishri Blakeley
8. Nimish Mohile
To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.